Examkin

Soru

Zorluk: ZorDiagnostic Workup and Test Sequencing

A 41-year-old woman presents to the clinic with an 8-month history of progressive central weight gain, severe fatigue, and proximal muscle weakness. She also reports the onset of facial hair growth and irregular menstrual cycles. Her blood pressure is 158/96 mmHg and her BMI is 33 kg/m^2. Physical examination reveals a rounded, plethoric face, prominent supraclavicular fat pads, and wide, violaceous striae on her abdomen. Laboratory results are notable for a serum potassium level of 3.1 mEq/L and a fasting blood glucose of 138 mg/dL. The physician suspects an endogenous hormonal excess syndrome.

Assuming that each diagnostic step yields findings that necessitate progression to the next level of workup for a central, adrenocorticotropic hormone (ACTH)-dependent etiology (with non-definitive initial imaging), arrange the following investigations in the most appropriate, guideline-directed sequence from initial screening to final confirmation.

  1. 1Measurement of 24-hour urine free cortisol or late-night salivary cortisol
  2. 2Measurement of plasma adrenocorticotropic hormone (ACTH) concentration
  3. 3Magnetic resonance imaging (MRI) of the pituitary gland
  4. 4Bilateral inferior petrosal sinus sampling (IPSS)

Cevap

The correct diagnostic sequence is: 1) Measure 24-hour urine free cortisol (or equivalent) to confirm hypercortisolism, 2) Measure plasma ACTH to determine dependence, 3) Perform pituitary MRI for non-invasive localization, and 4) Perform IPSS for definitive invasive localization.
The diagnostic workup of Cushing syndrome strictly follows a physiological cascade. Step 1 is biochemical confirmation of excessive cortisol (e.g., 24-hour urine free cortisol). Step 2 is determining the mechanism by measuring ACTH; suppressed ACTH directs workup to the adrenal glands, while normal/high ACTH directs it to a central or ectopic source. Step 3 is an MRI of the pituitary, as Cushing disease is the most common ACTH-dependent cause. Step 4 is IPSS, which is indicated only when the MRI is negative or reveals a lesion smaller than 6 mm, in order to definitively distinguish between a pituitary adenoma and ectopic ACTH syndrome.

Adım Adım Çözüm

1
Establish the diagnosis of hypercortisolism (Cushing syndrome).
24-hour urine free cortisol, late-night salivary cortisol, or a low-dose dexamethasone suppression test is positive.
Biochemical confirmation of excess cortisol must be established before investigating its source to prevent diagnostic anchoring and misdiagnosis.
2
Determine if the hypercortisolism is ACTH-dependent or ACTH-independent.
A plasma ACTH level is measured and found to be normal or elevated (>20 pg/mL).
This differentiates a primary adrenal source (suppressed ACTH) from a pituitary or ectopic source (normal/elevated ACTH). ACTH must be checked before imaging to avoid false-positive localization due to non-functioning incidentalomas.
3
Localize the source of ACTH production non-invasively.
An MRI of the pituitary gland is performed.
Since pituitary adenomas (Cushing disease) are the most common cause of ACTH-dependent Cushing syndrome, pituitary MRI is the appropriate first-line imaging study.
4
Confirm the central source invasively if non-invasive imaging is equivocal.
Bilateral IPSS is performed, showing a central-to-peripheral ACTH gradient.
Many pituitary microadenomas are too small (<6 mm) to be definitively diagnosed on MRI, and ectopic ACTH tumors can be occult. IPSS provides definitive differentiation between pituitary and ectopic sources.

Anahtar Kavram

The diagnostic algorithm for Cushing syndrome requires a strict stepwise approach to prevent errors from incidentalomas: first confirm hypercortisolism biochemically, then determine ACTH dependence, then localize non-invasively, and finally confirm invasively only if needed.
Bu soruyu puanla

Konular

Diagnostic Workup and Test Sequencing

Bu konudan daha fazla soru